Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
about
Approach to the patient with neutropenia in childhoodThe diversity of mutations and clinical outcomes for ELANE-associated neutropeniaCongenital neutropenia: diagnosis, molecular bases and patient management.Inherited bone marrow failure syndromes in adolescents and young adults.Genetic predisposition syndromes: when should they be considered in the work-up of MDS?Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.Neonatal manifestations of inherited bone marrow failure syndromes.Evaluation and management of patients with isolated neutropeniaSevere congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia.Transplantation for congenital bone marrow failure syndromes.Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.How I diagnose and treat neutropenia.ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiologyStochastic Hypothesis of Transition from Inborn Neutropenia to AML: Interactions of Cell Population Dynamics and Population GeneticsGenetic predispositions to childhood leukemia.Hematopoietic stem cell transplantation for severe congenital neutropenia.Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome.Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis.Germline Genetic Predisposition to Hematologic Malignancy.Severe congenital neutropenias.Understanding, treating and avoiding hematological disease: better medicine through mathematics?Old and new faces of neutropenia in children.Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.ELANE gene mutation-induced cyclic neutropenia manifesting as recurrent fever with oral mucosal ulcer: A case report.
P2860
Q26777106-802DC675-8475-42A9-AE62-E10AF892ED24Q26830241-F5D4D558-4FE6-4F1A-B8FC-CCB9D4B238AAQ33395402-712F50F4-46C8-44AA-95BF-2A9E1F492787Q33415672-9173658B-8284-4CAE-B2C0-B444C5D0888BQ33420216-522FE194-0395-48EE-841C-A4063CD1B151Q33428604-DE5E7549-401E-4EEA-AFED-B28A6318AFB7Q33428864-0C9D910D-1B6D-485E-B541-A53CBE74BC5CQ34364656-D64914EC-4DF1-4DAA-8C8E-12DC3497DCEFQ34477288-16CFE45A-3A71-4F29-8F38-153304C34839Q34857809-71BBA127-0AC9-4191-A0E0-378EA4AD93B2Q35428973-9D9E18C6-958E-487E-BE3B-F9474ED414B7Q35605853-C11AD47F-6597-4C4D-A73D-0BB02CFEF8E4Q36342838-AD0C2F3D-70CA-4C6C-8D50-EBE3B441D3A4Q36573828-FFE3952B-0F35-4B69-BF8B-F07E7EECFCBFQ36800416-3B78CE19-0C33-4D9D-87C9-F1A8C905853DQ37073895-DE0082DF-FB08-445A-B172-DBDF1FBC1A09Q37955726-39E3D2AE-D602-4339-8D43-57028DCFD4A8Q38073045-4EFA92F9-5705-4CAB-8620-7ACF70222967Q39105427-A7D42AD6-6029-4E6D-AD6A-A311E2381605Q39180483-882DE7BC-C791-4EDE-B792-38A5FE53CAE8Q39359222-80CB9A64-D317-47F8-B781-65B53FB28EBCQ41742420-7F5D4091-A797-498A-8624-18E90216CA78Q42399841-ADC7CC6C-44C1-4178-849C-D2A63A8D8196Q42958779-165EEE20-3CF6-4516-AE21-4FDEA2ECB35BQ52344023-3149CE4F-1546-4FA9-933B-2513DACB74D4Q54957218-4AF971E5-BDC4-49C5-9614-E235C5F1D694
P2860
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@ast
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@en
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@nl
type
label
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@ast
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@en
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@nl
prefLabel
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@ast
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@en
Stable long-term risk of leuka ...... a maintained on G-CSF therapy.
@nl
P2093
P2860
P1476
Stable long-term risk of leuka ...... ia maintained on G-CSF therapy
@en
P2093
Akiko Shimamura
Audrey A Bolyard
Blanche P Alter
Cornelia Zeidler
Daniel C Link
David C Dale
Karl Welte
Laurence A Boxer
Mary A Bonilla
Sally Kinsey
P2860
P304
P356
10.1111/J.1365-2141.2010.08216.X
P407
P577
2010-04-29T00:00:00Z